PRO-157

pazufloxacin · Laboratorios Sophia S.A de C.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-157, covering 2019-02-15 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) [Phase 2]

See pricing